GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optomed PLC (FRA:36U0) » Definitions » Float Percentage Of Total Shares Outstanding

Optomed (FRA:36U0) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 18, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Optomed Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Optomed's float shares is 0.00 Mil. Optomed's total shares outstanding is 19.66 Mil. Optomed's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Optomed's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Optomed's Institutional Ownership is 31.26%.


Optomed Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Optomed's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/19.66
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optomed Business Description

Industry
Traded in Other Exchanges
Address
Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.

Optomed Headlines

No Headlines